These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 1651082)

  • 21. Processing of MPTP by monoamine oxidases: implications for molecular toxicology.
    Trevor AJ; Singer TP; Ramsay RR; Castagnoli N
    J Neural Transm Suppl; 1987; 23():73-89. PubMed ID: 3295117
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Reversible inhibition and mechanism-based irreversible inactivation of monoamine oxidases by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP).
    Singer TP; Salach JI; Crabtree D
    Biochem Biophys Res Commun; 1985 Mar; 127(2):707-12. PubMed ID: 3872126
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Studies on the molecular mechanism of bioactivation of the selective nigrostriatal toxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine.
    Chiba K; Peterson LA; Castagnoli KP; Trevor AJ; Castagnoli N
    Drug Metab Dispos; 1985; 13(3):342-7. PubMed ID: 2861994
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of MPTP and its pyridinium metabolites on monoamine uptake and on central catecholamine neurons in mice.
    Jonsson G; Nwanze E; Luthman J; Sundström E
    Acta Physiol Scand; 1986 Oct; 128(2):187-94. PubMed ID: 3535380
    [TBL] [Abstract][Full Text] [Related]  

  • 25. 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP), its metabolite cyperquat (MPP+) and energy transduction in mitochondria from rat striatum and liver.
    Thakar JH; Hassan MN; Grimes JD
    Prog Neuropsychopharmacol Biol Psychiatry; 1988; 12(2-3):355-62. PubMed ID: 3260387
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Neurotoxic damage to the nigrostriatal system in rats following intranigral administration of MPDP+ and MPP+.
    Sun CJ; Johannessen JN; Gessner W; Namura I; Singhaniyom W; Brossi A; Chiueh CC
    J Neural Transm; 1988; 74(2):75-86. PubMed ID: 3266233
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Metabolic studies on the nigrostriatal toxin MPTP and its MAO B generated dihydropyridinium metabolite MPDP+.
    Wu E; Shinka T; Caldera-Munoz P; Yoshizumi H; Trevor A; Castagnoli N
    Chem Res Toxicol; 1988; 1(3):186-94. PubMed ID: 2979730
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Structure-neurotoxicity trends of analogues of 1-methyl-4-phenylpyridinium (MPP+), the cytotoxic metabolite of the dopaminergic neurotoxin MPTP.
    Arora PK; Riachi NJ; Fiedler GC; Singh MP; Abdallah F; Harik SI; Sayre LM
    Life Sci; 1990; 46(5):379-90. PubMed ID: 2304377
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A model of chronic neurotoxicity: long-term retention of the neurotoxin 1-methyl-4-phenylpyridinium (MPP+) within catecholaminergic neurons.
    Johannessen JN
    Neurotoxicology; 1991; 12(2):285-302. PubMed ID: 1956587
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mechanism of the neurotoxicity of 1-methyl-4-phenylpyridinium (MPP+), the toxic bioactivation product of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP).
    Singer TP; Ramsay RR; McKeown K; Trevor A; Castagnoli NE
    Toxicology; 1988 Apr; 49(1):17-23. PubMed ID: 3287690
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Rapid reduction of ATP synthesis and lack of free radical formation by MPP+ in rat brain synaptosomes and mitochondria.
    Fonck C; Baudry M
    Brain Res; 2003 Jun; 975(1-2):214-21. PubMed ID: 12763610
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Biotransformation of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in primary cultures of mouse astrocytes.
    Di Monte DA; Wu EY; Irwin I; Delanney LE; Langston JW
    J Pharmacol Exp Ther; 1991 Aug; 258(2):594-600. PubMed ID: 1907660
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Theoretical studies on mechanism of MPTP action: ET interference by MPP+ (1-methyl-4-phenylpyridinium) with mitochondrial respiration vs. oxidative stress.
    Kovacic P; Edwards WD; Ming G
    Free Radic Res Commun; 1991; 14(1):25-32. PubMed ID: 2022343
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP), cyperquat (MPP+) and paraquat on isolated mitochondria from rat striatum, cortex and liver.
    Thakar JH; Hassan MN
    Life Sci; 1988; 43(2):143-9. PubMed ID: 3260653
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Energy-driven uptake of N-methyl-4-phenylpyridine by brain mitochondria mediates the neurotoxicity of MPTP.
    Ramsay RR; Dadgar J; Trevor A; Singer TP
    Life Sci; 1986 Aug; 39(7):581-8. PubMed ID: 3488484
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Further insight into the mode of action of the neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP).
    Gessner W; Brossi A; Shen RS; Abell CW
    FEBS Lett; 1985 Apr; 183(2):345-8. PubMed ID: 3872811
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Metabolism of [14C]MPTP in mouse and monkey implicates MPP+, and not bound metabolites, as the operative neurotoxin.
    Yang SC; Johannessen JN; Markey SP
    Chem Res Toxicol; 1988; 1(4):228-33. PubMed ID: 2979736
    [TBL] [Abstract][Full Text] [Related]  

  • 38. N-methyl-4-phenylpyridine (MMP+) together with 6-hydroxydopamine or dopamine stimulates Ca2+ release from mitochondria.
    Frei B; Richter C
    FEBS Lett; 1986 Mar; 198(1):99-102. PubMed ID: 3082673
    [TBL] [Abstract][Full Text] [Related]  

  • 39. MPP+ and MPDP+ induced oxygen radical formation with mitochondrial enzymes.
    Adams JD; Klaidman LK; Leung AC
    Free Radic Biol Med; 1993 Aug; 15(2):181-6. PubMed ID: 8397143
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Melatonin protects against MPTP/MPP+ -induced mitochondrial DNA oxidative damage in vivo and in vitro.
    Chen LJ; Gao YQ; Li XJ; Shen DH; Sun FY
    J Pineal Res; 2005 Aug; 39(1):34-42. PubMed ID: 15978055
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.